CS13 CLINICAL EFFECTIVENESS AND COST UTILITY OF TRUVADA, KIVEXA AND COMBIVIR IN THE TREATMENT OF ANTIRETROVIRAL NAVE HIV-1 INFECTED PATIENTS IN MEXICO
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75316-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)75316-X/fulltext
Title :
CS13 CLINICAL EFFECTIVENESS AND COST UTILITY OF TRUVADA, KIVEXA AND COMBIVIR IN THE TREATMENT OF ANTIRETROVIRAL NAVE HIV-1 INFECTED PATIENTS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75316-X&doi=10.1016/S1098-3015(10)75316-X
First page :
Section Title :
Open access? :
No
Section Order :
1241